Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1

Our retrospective study showed inhibition of the renin–angiotensin system was associated with better outcomes in patients with advanced pancreatic cancer receiving gemcitabine. The primary objective of this phase I study was to determine the recommended dose of candesartan in combination with gemcit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Nakai, Yousuke, Isayama, Hiroyuki, Ijichi, Hideaki, Sasaki, Takashi, Kogure, Hirofumi, Yagioka, Hiroshi, Miyabayashi, Koji, Mizuno, Suguru, Yamamoto, Keisuke, Mouri, Dai, Kawakubo, Kazumichi, Yamamoto, Natsuyo, Hirano, Kenji, Sasahira, Naoki, Tateishi, Keisuke, Tada, Minoru, Koike, Kazuhiko
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2012
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659287/
https://ncbi.nlm.nih.gov/pubmed/22515232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02311.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars